126 related articles for article (PubMed ID: 11315594)
1. Diagnosis of recurrent head and neck squamous cell carcinoma with 3-[123I]iodo-L-alpha-methyltyrosine SPET.
Dierickx LO; Lahoutte T; Deron P; Caveliers V; Vanhove C; Everaert H; Bossuyt A
Eur J Nucl Med; 2001 Mar; 28(3):282-7. PubMed ID: 11315594
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the response to therapy of head and neck squamous cell carcinoma by using 3-[123I]iodo-L-alpha-methyl tyrosine and single photon emission tomography.
Dierickx LO; Everaert H; Deron P; Voordeckers M; Lahoutte T; Bossuyt A
Nucl Med Commun; 2003 Jun; 24(6):633-41. PubMed ID: 12766598
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
Bader JB; Samnick S; Moringlane JR; Feiden W; Schaefer A; Kremp S; Kirsch CM
Eur J Nucl Med; 1999 Feb; 26(2):144-51. PubMed ID: 9933348
[TBL] [Abstract][Full Text] [Related]
4. Iodine-123 alpha-methyl-l-tyrosine single-photon emission tomography for the visualization of head and neck squamous cell carcinomas.
Flamen P; Bernheim N; Deron P; Caveliers V; Chavatte K; Franken PR; Bossuyt A
Eur J Nucl Med; 1998 Feb; 25(2):177-81. PubMed ID: 9473267
[TBL] [Abstract][Full Text] [Related]
5. Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl- L-tyrosine and 99mTc-MIBI SPET.
Henze M; Mohammed A; Schlemmer H; Herfarth KK; Mier W; Eisenhut M; Debus J; Haberkorn U
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1455-61. PubMed ID: 12397464
[TBL] [Abstract][Full Text] [Related]
6. 3-[123I]Iodo-alpha-methyl-L-tyrosine uptake in cerebral gliomas: relationship to histological grading and prognosis.
Schmidt D; Gottwald U; Langen KJ; Weber F; Hertel A; Floeth F; Felsberg J; Reifenberger G; Coenen HH; Müller-Gärtner HW
Eur J Nucl Med; 2001 Jul; 28(7):855-61. PubMed ID: 11504082
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of 123I-IMT SPECT in the follow-up of head and neck cancer.
Plotkin M; Wurm R; Kuczer D; Wust P; Michel R; Denecke T; Ruf J; Schlenger L; Bischoff A; Felix R; Amthauer H
Onkologie; 2006 Apr; 29(4):147-52. PubMed ID: 16601370
[TBL] [Abstract][Full Text] [Related]
8. Clinical value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up.
Samnick S; Bader JB; Hellwig D; Moringlane JR; Alexander C; Romeike BF; Feiden W; Kirsch CM
J Clin Oncol; 2002 Jan; 20(2):396-404. PubMed ID: 11786566
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment evaluation of carcinomas of the hypopharynx and larynx with 18F-fluorodeoxyglucose, 123I-alpha-methyl-L-tyrosine and 99mTc-hexakis-2-methoxyisobutylisonitrile.
Henze M; Mohammed A; Mier W; Rudat V; Dietz A; Nollert J; Eisenhut M; Haberkorn U
Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):324-30. PubMed ID: 12002706
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 201 Tl- with 67 Ga single photon emission tomography in the diagnosis of head and neck cancer recurrence.
Yamamoto Y; Nishiyama Y; Toyama Y; Ohbayashi Y; Iwasaki A; Satoh K; Ohkawa M
Nucl Med Commun; 2002 Feb; 23(2):187-91. PubMed ID: 11891475
[TBL] [Abstract][Full Text] [Related]
11. Sequential scintigraphic strategy for the differentiation of brain tumours.
Matheja P; Rickert C; Weckesser M; Palkovic S; Löttgen J; Riemann B; Kopka K; Kuwert T; Wassmann H; Paulus W; Schober O
Eur J Nucl Med; 2000 May; 27(5):550-8. PubMed ID: 10853811
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose.
Woesler B; Kuwert T; Morgenroth C; Matheja P; Palkovic S; Schäfers M; Vollet B; Schäfers K; Lerch H; Brandau W; Samnick S; Wassmann H; Schober O
Eur J Nucl Med; 1997 Apr; 24(4):428-34. PubMed ID: 9096095
[TBL] [Abstract][Full Text] [Related]
13. 123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.
Plotkin M; Eisenacher J; Bruhn H; Wurm R; Michel R; Stockhammer F; Feussner A; Dudeck O; Wust P; Felix R; Amthauer H
J Neurooncol; 2004 Oct; 70(1):49-58. PubMed ID: 15527107
[TBL] [Abstract][Full Text] [Related]
14. Combined SPECT/CT imaging using 123I-IMT in the detection of recurrent or persistent head and neck cancer.
Plotkin M; Wurm R; Eisenacher J; Szerewicz K; Michel R; Schlenger L; Pech M; Denecke T; Kuczer D; Bischoff A; Felix R; Amthauer H
Eur Radiol; 2006 Feb; 16(2):503-11. PubMed ID: 15983775
[TBL] [Abstract][Full Text] [Related]
15. Technetium-99m-MIBI in primary and recurrent head and neck tumors: contribution of bone SPECT image fusion.
Leitha T; Glaser C; Pruckmayer M; Rasse M; Millesi W; Lang S; Nasel C; Backfrieder W; Kainberger F
J Nucl Med; 1998 Jul; 39(7):1166-71. PubMed ID: 9669388
[TBL] [Abstract][Full Text] [Related]
16. High uptake of L-3-[123I]iodo-alpha-methyl tyrosine in pilocytic astrocytomas.
Weckesser M; Matheja P; Rickert CH; Sträter R; Palkovic S; Löttgen J; Kurlemann G; Paulus W; Wassmann H; Schober O
Eur J Nucl Med; 2001 Mar; 28(3):273-81. PubMed ID: 11315593
[TBL] [Abstract][Full Text] [Related]
17. Imaging of soft-tissue tumors using L-3-[iodine-123]iodo-alpha-methyl-tyrosine single photon emission computed tomography: comparison with proliferative and mitotic activity, cellularity, and vascularity.
Jager PL; Plaat BE; de Vries EG; Molenaar WM; Vaalburg W; Piers DA; Hoekstra HJ
Clin Cancer Res; 2000 Jun; 6(6):2252-9. PubMed ID: 10873075
[TBL] [Abstract][Full Text] [Related]
18. Whole-body kinetics and dosimetry of L-3--123I-iodo-alpha-methyltyrosine.
Schmidt D; Langen KJ; Herzog H; Wirths J; Holschbach M; Kiwit JC; Ziemons K; Coenen HH; Müller-Gärtner H
Eur J Nucl Med; 1997 Sep; 24(9):1162-6. PubMed ID: 9283111
[TBL] [Abstract][Full Text] [Related]
19. 99Tc(m) labelled HL91 versus computed tomography and biopsy for the visualization of tumour recurrence of squamous head and neck carcinoma.
Van De Wiele C; Versijpt J; Dierckx RA; Moerman M; Lemmerling M; D'Asseler Y; Vermeersch H
Nucl Med Commun; 2001 Mar; 22(3):269-75. PubMed ID: 11314758
[TBL] [Abstract][Full Text] [Related]
20. Comparison of thallium-201 SPET and CT/MRI in the detection of residual/recurrent squamous cell carcinoma of the oral cavity.
Lee JK; Tyan YS; Huang WS
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):528-31. PubMed ID: 14722682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
